Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03680157 · ClinicalTrials.gov registry record

Comparing Rater Reliability of Familiar Practitioners to Blinded Coders

A clinical trial of Premature Birth and Child Development, sponsored by Columbia University.

Completed
Registry status
90
Enrollment target
1
Study location

NCT03680157 is a study of Premature Birth and Child Development that has completed, run by Columbia University. The registered enrollment target is 90 participants, below the 392-participant average among 38 other Premature Birth trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03680157, a study of Premature Birth and Child Development, has completed, sponsored by Columbia University.

COMPLETED
Registry status
90 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine how coders who have seen multiple time points of the same dyad, and are therefore familiar with the case, rate emotional connection using the WECS compared to coders who are blinded to the case's previous time points. The investigator hypothesizes that the WECS will show external validity: that all coders will have high reliability on their WECS scores, despite exposure to the dyads' past videos by the clinical coders.

Study Locations (1)

New York

  • Columbia University Medical Center - New York

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2018-09-30
Est. Completion 2019-08-23

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT03680157

The ClinicalTrials.gov registry entry for NCT03680157 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 392-participant average among 38 other Premature Birth trials with a reported enrollment target (77% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Premature Birth appearing as the primary indexed condition, and to 0 interventions.

NCT03680157 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03680157 about?

NCT03680157 is a clinical study titled "Comparing Rater Reliability of Familiar Practitioners to Blinded Coders". The purpose of this study is to determine how coders who have seen multiple time points of the same dyad, and are therefore familiar with the case, rate emotional connection using the WECS compared to coders who are blinded to the case's previous time points. The investigator hypothesizes that the ...

What is the current status of trial NCT03680157?

This trial is currently completed. The enrollment target is 90 participants. The study started on 2018-09-30. Estimated completion is 2019-08-23.

What conditions does trial NCT03680157 study?

This clinical trial studies the following conditions: Premature Birth, Child Development.

Who is sponsoring clinical trial NCT03680157?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03680157 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Premature Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.